Skip to Content

News Releases

Jan 08 2023
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results
ALISO VIEJO, Calif. , Jan. 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) –  RxSight, Inc. , an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth